Results Of The
AH1N1 Vaccine Testing In Costa Rica To Be
Ready In Three Weeks
A week ago 784 Costa Ricans aged from three
to sixty-four years of age began AH1N1
vaccine trials that is also being done in
the United States and Mexico in the search
for a vaccine against the AH1N1 flu virus.
The Costa Rican results of a possible
vaccine against the virus are expected
within a month.
The trials in Costa Rica are being conducted
by the Swiss pharmaceutical, Novartis, at
the Centro de Atención Pediátrica located on
Paseo Colón in San José.
Novartis is one of six international firms
conducting trials in search for an AH1N1
vaccine.
Depending on the trials results, a vaccine
could start to be marketed as early as the
end of September or early October.
The final decision on the vaccination will
be up to the World Health Organization
(WHO).
|
|
|
|
|
| |
|
|
|
|
|
